Compare GOLF & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOLF | INDV |
|---|---|---|
| Founded | 1910 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.4B |
| IPO Year | 2016 | 2014 |
| Metric | GOLF | INDV |
|---|---|---|
| Price | $88.83 | $36.13 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $83.67 | N/A |
| AVG Volume (30 Days) | 330.1K | ★ 2.1M |
| Earning Date | 05-06-2026 | 06-08-2026 |
| Dividend Yield | ★ 1.07% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | ★ 1.36 | 0.69 |
| Revenue | ★ $1,633,721,000.00 | $1,239,000,000.00 |
| Revenue This Year | $5.76 | N/A |
| Revenue Next Year | $2.44 | N/A |
| P/E Ratio | $65.26 | ★ $53.12 |
| Revenue Growth | ★ 4.71 | 4.29 |
| 52 Week Low | $67.14 | $12.30 |
| 52 Week High | $104.81 | $41.00 |
| Indicator | GOLF | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 47.22 |
| Support Level | $82.57 | $35.36 |
| Resistance Level | $103.88 | $37.43 |
| Average True Range (ATR) | 2.64 | 1.08 |
| MACD | 0.46 | -0.41 |
| Stochastic Oscillator | 58.85 | 13.84 |
Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).